the price action here is kind of blowing my mind.
Commsec dominating the selling of ARL and buying of CLQ lends some support to the idea we are seeing a complete misunderstanding that ARL is in fact ~ 6-7x undervalued to CLQ (if we assume they are primarily valued on their N/Co deposits, and those deposits are give or take equals).
I know this sounds ridiculous but I see this on HC threads all the time - punters like buying stocks that are cheap in raw $ terms, ignoring market cap. This also helps explains the herd action at AUZ from retail IMO.
The other factor seems to be concern over financing, noting COB has had a nice green bounce after telling the market finance won't be a problem. I note CLQ did this in an AFR article, but I don't think they did a release to market on this.
If all this is true, we either need CLQ to start climbing again, or some specific announcements from ARL around financing, offtake and/or such compelling economics from scoping on 2.25Mt option, that the institutions twig and buy hard... all IMO. GLTAH. Trying times...
- Forums
- ASX - By Stock
- ARL
- ARL chart
ARL chart, page-524
-
-
- There are more pages in this discussion • 3,328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARL (ASX) to my watchlist
(20min delay)
|
|||||
Last
41.0¢ |
Change
0.010(2.50%) |
Mkt cap ! $81.86M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 40.0¢ | $1.304K | 3.194K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 855 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 7500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 855 | 0.400 |
5 | 253196 | 0.395 |
1 | 3589 | 0.390 |
1 | 48085 | 0.385 |
1 | 1500 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 7500 | 2 |
0.440 | 16590 | 1 |
0.450 | 20000 | 1 |
0.470 | 660 | 1 |
0.475 | 10500 | 1 |
Last trade - 12.05pm 13/11/2024 (20 minute delay) ? |
Featured News
ARL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online